Retinopathy - hypertensive
Methodology & AI Transparency ⓘ
Retinopathy - hypertensive Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Within Eye Health, Glaucoma & Vision Disorders practice, Retinopathy - hypertensive (ICD-10 H35.039) is stratified through or microsurgical intervention [Retinopathy - hypertensive H35.039], pairing targeted symptom control with longitudinal Best-Corrected Visual Acuity in Retinopathy - hypertensive (H35.039: & OCT) surveillance.
- 2 Real-world patient consensus: Federal ICD-10-CM code H35.039 categorizes Retinopathy - hypertensive under Eye Health, Glaucoma & Vision Disorders.
- 3 Typical cash cost range: Workup highlights for Retinopathy - hypertensive (H35.039): or microsurgical intervention [Retinopathy - hypertensive H35.039].
- 4 Top reported side effects / signs: Key Eyes & Vision biomarkers for Retinopathy - hypertensive (H35.039): Intraocular Pressure (IOP) [Retinopathy - hypertensive H35.039] & Best-Corrected Visual Acuity in Retinopathy - hypertensive (H35.039: & OCT) (Intact retinal nerve fiber & macula (H35.039)).
Ask our AI Specialists anything about Retinopathy - hypertensive
What Is Retinopathy - hypertensive?
Within Eye Health, Glaucoma & Vision Disorders practice, Retinopathy - hypertensive (ICD-10 H35.039) is stratified through or microsurgical intervention [Retinopathy - hypertensive H35.039], pairing targeted symptom control with longitudinal Best-Corrected Visual Acuity in Retinopathy - hypertensive (H35.039: & OCT) surveillance.
Pathophysiology, Underlying Causes & Clinical Presentation
Biological expression of Retinopathy - hypertensive (H35.039, Eyes & Vision) reflects impaired trabecular meshwork in Retinopathy - hypertensive (H35.039: aqueous humor outflow). longitudinal control is benchmarked via Intraocular Pressure (IOP) [Retinopathy - hypertensive H35.039].
Common Symptoms & Clinical Signs
- • Presentation of Retinopathy - hypertensive (H35.039): gradual blurring, glare/halos in Retinopathy - hypertensive (H35.039: around nighttime headlights,)
- • Secondary Retinopathy - hypertensive clinical sign: gritty burning, foreign-body in Retinopathy - hypertensive (H35.039: sensation, reflex tearing,)
- • Symptom flares in Retinopathy - hypertensive correlating with Intraocular Pressure (IOP) [Retinopathy - hypertensive H35.039] deviation outside 10 – 21 mmHg (individualized optic target) (H35.039)
- • Functional eyes & vision impact requiring or microsurgical intervention [Retinopathy - hypertensive H35.039] evaluation (H35.039)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Retinopathy - hypertensive Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | H35.039 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Eye Health, Glaucoma & Vision Disorders | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Intraocular Pressure (IOP) [Retinopathy - hypertensive H35.039] | 10 – 21 mmHg (individualized optic target) (H35.039) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Best-Corrected Visual Acuity in Retinopathy - hypertensive (H35.039: & OCT) | Intact retinal nerve fiber & macula (H35.039) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: HbA1c & Systemic in Retinopathy - hypertensive (H35.039: Blood Pressure) | Microvascular retinal protection (H35.039) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Retinopathy - hypertensive
Treatment selection for Retinopathy - hypertensive depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Retinopathy - hypertensive)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Resolution of outer retinal abnormalities in eyes with vitreomacular traction ELM disruption, EZ disruption and/or SRF are present in a significant percentage of eyes with VMT without MH. The British journal of ophthalmology • 2023-07-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 35288439 ↗ |
| New Insights on Panretinal Photocoagulation for Diabetic Retinopathy in the RIDE and RISE Trials:: What a 577-Participant Study Found In RIDE and RISE, PRP treatment was not a "1 and done" procedure, with on-study PRP re-treatment occurring in patients both with and without prior PRP treatment at baseline. Ophthalmology • 2021-10-15 • Phase III Randomized Trial | N = 577 | 87/100 | PMID 31668888 ↗ |
| New Insights on Longitudinal Prediction of Retinal Sensitivity Based on Disease Progression: What a 406-Participant Study Found Two exploratory endpoints were developed, namely quantification of EZ thickness and loss, and localized RS within high-risk OCT areas. Investigative ophthalmology & visual science • 2026-09-01 • Phase III Randomized Trial | N = 406 | 87/100 | PMID 42742213 ↗ |
| What the Latest Evidence Really Says About Multidimensional sleep health and diabetic retinopathy: Systematic review and The results were mixed among studies, but potential benefits were observed in some. Sleep medicine reviews • 2024-04-15 • Meta-Analysis | Multi-cohort | 86/100 | PMID 38118339 ↗ |
| Can This Approach Help? Inside the Latest Research on Patient-Reported Outcomes after Surgery for Proliferative Vitreoretinopathy: Post Introduction: Proliferative vitreoretinopathy (PVR) is the leading cause of surgical failure in rhegmatogenous retinal detachment (RRD) and is associated with poor visual prognosis. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde • 2026-01-15 • Phase III Randomized Trial | N = 139 | 82/100 | PMID 41610080 ↗ |
Retinopathy - hypertensive Patient Community & “People Like Me” Threads
Filter Retinopathy - hypertensive community threads and patient logs by age, biological sex, dosage, and treatment duration.